Ivacaftor and Airway Inflammation in Preschool Children with Cystic Fibrosis

被引：16

作者：

McNally, Paul ^{[1
,2
]}

Butler, Daryl ^{[1
,2
]}

Karpievitch, Yuliya V. ^{[3
,4
]}

Linnane, Barry ^{[1
,5
]}

Ranganathan, Sarath ^{[6
,7
,8
]}

Stick, Stephen M. ^{[3
,4
,9
]}

Hall, Graham L. ^{[4
,10
]}

Schultz, Andre

机构：

[1] Childrens Hlth Ireland, Dublin, Ireland

[2] Ireland Univ Med & Hlth Sci, Royal Coll Surg, Dublin, Ireland

[3] Univ Western Australia, Perth, WA, Australia

[4] Telethon Kids Inst, Perth, WA, Australia

[5] Univ Limerick, Limerick, Ireland

[6] Univ Melbourne, Melbourne, Vic, Australia

[7] Royal Childrens Hosp, Parkville, Vic, Australia

[8] Murdoch Childrens Res Inst, Parkville, Vic, Australia

[9] Perth Childrens Hosp, Nedlands, WA, Australia

[10] Curtin Univ, Bentley, WA, Australia

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 204卷 / 05期

关键词：

EFFICACY; PHASE-3; SAFETY;

D O I：

10.1164/rccm.202012-4332LE

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：605 / 608

页数：5

共 11 条

[1] Long-term computed tomographic changes in cystic fibrosis patients treated with ivacaftor [J].

Chassagnon, Guillaume ;

Hubert, Dominique ;

Fajac, Isabelle ;

Burgel, Pierre-Regis ;

Revel, Marie-Pierre .

EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (01) :249-252

[2] Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study [J].

Davies, Jane C. ;

Cunningham, Steve ;

Harris, William T. ;

Lapey, Allen ;

Regelmann, Warren E. ;

Sawicki, Gregory S. ;

Southern, Kevin W. ;

Robertson, Sarah ;

Green, Yulia ;

Cooke, Jon ;

Rosenfeld, Margaret .

LANCET RESPIRATORY MEDICINE, 2016, 4 (02) :107-115

[3]

Hisert KB, 2017, AM J RESP CRIT CARE, V195, P1617, DOI [10.1164/rccm.201609-1954OC, 10.1164/rccm.201609-1954oc]

[4]

McKone EF, 2014, LANCET RESP MED, V2, P902, DOI [10.1016/S2213-2600(14)70218-8, 10.1016/s2213-2600(14)70218-8]

[5] Pooling of bronchoalveolar lavage in children with cystic fibrosis does not adversely affect the microbiological yield or sensitivity in detecting pulmonary inflammation [J].

McNally, Paul ;

O'Rourke, Jennifer ;

Fantino, Emmanuelle ;

Chacko, Archana ;

Pabary, Rishi ;

Turnbull, Andrew ;

Grant, Tim ;

O'Sullivan, Niamh ;

Wainwright, Claire ;

Linnane, Barry ;

Davies, Jane C. ;

Sly, Peter D. .

JOURNAL OF CYSTIC FIBROSIS, 2018, 17 (03) :391-399

[6]

Ratjen F, 2012, EUR RESPIR J, V40, P1841

[7] Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled, phase 3 trial [J].

Ratjen, Felix ;

Hug, Christopher ;

Marigowda, Gautham ;

Tian, Simon ;

Huang, Xiaohong ;

Stanojevic, Sanja ;

Milla, Carlos E. ;

Robinson, Paul D. ;

Waltz, David ;

Davies, Jane C. .

LANCET RESPIRATORY MEDICINE, 2017, 5 (07) :557-567

[8] Reduced 15-lipoxygenase 2 and lipoxin A4/leukotriene B4 ratio in children with cystic fibrosis [J].

Ringholz, Fiona C. ;

Buchanan, Paul J. ;

Clarke, Donna T. ;

Millar, Roisin G. ;

McDermott, Michael ;

Linnane, Barry ;

Harvey, Brian J. ;

McNally, Paul ;

Urbach, Valerie .

EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (02) :394-404

[9] Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis [J].

Rowe, Steven M. ;

Heltshe, Sonya L. ;

Gonska, Tanja ;

Donaldson, Scott H. ;

Borowitz, Drucy ;

Gelfond, Daniel ;

Sagel, Scott D. ;

Khan, Umer ;

Mayer-Hamblett, Nicole ;

Van Dalfsen, Jill M. ;

Joseloff, Elizabeth ;

Ramsey, Bonnie W. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 190 (02) :175-184

[10] Risk Factors for Bronchiectasis in Children with Cystic Fibrosis [J].

Sly, Peter D. ;

Gangell, Catherine L. ;

Chen, Linping ;

Ware, Robert S. ;

Ranganathan, Sarath ;

Mott, Lauren S. ;

Murray, Conor P. ;

Stick, Stephen M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (21) :1963-1970

← 1 2 →